rituximab,bendamustine
teva
['ritux', 'lymsm', 'imab ']
fascinating study for us indolent #lymsm nerds: 30% of pts with mzl have m-protein at diagnosis, and presence of m-spike is associated with advanced-stage dx and inferior pfs. benda+rituximab appears to mitigate this inferior pfs risk compared to rituximab monotherapy. #ash22 
#lymsm & #mmsm hematologist & patient-reported outcomes researcher @CUHematology. Founder of https://t.co/kN6qeGXfg5, @inTrainingDoc & @inHouseMag. ??????